| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
| mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.18 |
0.0001 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0002 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
| mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
0.0003 |
| mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0004 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |